Factors influencing antibiotic treatment cost and outcome in critically ill patients: A “real-life” study | Zendy

Aneta V. Perić | Zendy; Maja Šurbatović | Zendy; Sandra Vezmar Kovačević | Zendy; Mirjana Antunović | Zendy; Milić Veljović | Zendy; Dragan Djordjević | Zendy; Tamara Andjelic | Zendy; Snježana Zeba | Zendy; Silva Dobrić | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Factors influencing antibiotic treatment cost and outcome in critically ill patients: A “real-life” study

Author(s) -

Aneta V. Perić,

Maja Šurbatović,

Sandra Vezmar Kovačević,

Mirjana Antunović,

Milić Veljović,

Dragan Djordjević,

Tamara Andjelic,

Snježana Zeba,

Silva Dobrić

Publication year - 2014

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp1412102p

Subject(s) - medicine , procalcitonin , sepsis , intensive care unit , intensive care medicine , critically ill , intensive care , anesthesiology , antibiotics , mortality rate , emergency medicine , anesthesia , microbiology and biotechnology , biology

BACKGROUND/AIM. Critically ill patients are at very high risk of developing severe infections in intensive care units (ICUs). Procalcitonin (PCT) levels are eleveted in the circulation in patients with bacterial sepsis and PCT might be useful in guiding antibiotic treatment. The aim of this study was to estimate factors influencing patients survival and treatment cost in ICU with special emphasis on the impact of PCT serum levels use in guiding antimicrobial therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research